about
Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid.Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms.Second generation anticonvulsant medications: their use in children.Antiepileptic drugs: how they work in headache.Antiepileptic drugs in migraine prevention.The use of topiramate in mood stabilization.Acute topiramate overdose--clinical manifestations.Drug points: Weight loss associated with levetiracetam.Role of valproate across the ages. Treatment of epilepsy in children.Prevention and treatment of post-traumatic epilepsy.Topiramate in the treatment of partial and generalized epilepsy.Psychopharmacology of topiramate: from epilepsy to bipolar disorder.Effects of epilepsy treatments on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics.Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect.Add-on Effect of Levetiracetam on Cognitive Activity of Carbamazepine and Topiramate Treated Healthy Rats.Epilepsy, antiseizure therapy, and sleep cycle parameters.Clinical experience with topiramate dosing and serum levels in children 12 years or under with epilepsy.Acute topiramate toxicity.Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy.Topiramate induced peripheral neuropathy: A case report and review of literature.Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.Newer anticonvulsants: lamotrigine, topiramate and gabapentin.Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome.
P2860
Q33723355-B02F5008-4D50-4824-B964-7D8D528ACC70Q34345252-7A71FC45-DED9-43F2-AF62-473CD6CE7F88Q34555652-C3CDD45F-8B94-4F91-B6C3-F80E661E14C8Q34570655-27912104-61A3-469D-A887-3FEEE1D3CF77Q34570667-9CAEEDC9-7D05-43B8-8112-38FCC691881BQ34709943-425F5663-05AD-4B48-9F0A-A5AA71D007B2Q34985964-CEAE5EB4-D812-497E-80E1-6E98EBAEC3B8Q36351935-E33F2761-497B-4E20-A53F-3AC44E2728C0Q36507532-E4516CD2-5D6A-4395-986A-A2347ED39A24Q36558692-A053CAEC-0293-4DBD-BB50-EE9D18270725Q37129817-9AC25ECC-796E-4953-941C-A9F07AD5D727Q37166152-6CD63A91-3F94-41C0-9EC0-29A0BE0E6962Q38168295-EA251855-8B2B-4C0C-B46F-D0D6575A9941Q40558642-BDB8E9D5-A014-47B4-9D00-F84D99942F55Q42417084-FE3D6C68-2E78-4786-A849-4E5B49DCD8B0Q42562997-3F8FDF10-C741-445B-8CD2-EC4F3C554933Q43815296-F2080D1E-E0E0-4227-AD11-2D5B04F243CFQ44713657-A1E5688E-AD6B-4C65-ADF1-A2AED4EC2B10Q46648136-FA137A98-B097-42EB-8726-786A4DD1A3C4Q49249908-D50C63B0-3A26-42FA-BFC5-E25E9691C779Q49629769-1430BBB7-6FD1-4609-ACC2-F87D2537EA0FQ50799679-F21FD7A2-2BA6-4D43-9D7B-B8C31B4E6FD0Q53472676-7CFD3F64-855C-4BF6-B7F1-6200FC7235DE
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Topiramate.
@ast
Topiramate.
@en
type
label
Topiramate.
@ast
Topiramate.
@en
prefLabel
Topiramate.
@ast
Topiramate.
@en
P2860
P1433
P1476
Topiramate.
@en
P2093
T A Glauser
P2860
P304
P356
10.1111/J.1528-1157.1999.TB00922.X
P478
40 Suppl 5
P577
1999-01-01T00:00:00Z